Showing results (171-180 of 210) with videos related to

Sort By:
Pageof 21
Journal of Neural Transmission (Vienna, Austria : 1996)|June 17, 2005
A prospective study of serum ghrelin levels in patients treated with clozapineF M Theisen, S Gebhardt, T Brömel, et al.
Molecular Psychiatry|October 14, 2000
Leptin suppresses semi-starvation induced hyperactivity in rats: implications for anorexia nervosaC Exner, J Hebebrand, H Remschmidt, et al.
The Journal of Clinical Endocrinology and Metabolism|October 13, 1998
Systematic mutation screening of the pro-opiomelanocortin gene: identification of several genetic variants including three different insertions, one nonsense and two missense point mutations in probands of different weight extremesA Hinney, I Becker, O Heibült, et al.
American Journal of Medical Genetics|April 17, 1999
Tourette syndrome and the norepinephrine transporter gene: results of a systematic mutation screeningG Stöber, J Hebebrand, S Cichon, et al.
European Journal of Pediatrics|March 1, 1995
Strabismus in very low birth weight and/or very preterm children: discrepancy between age of onset and start of treatmentJ W Pott, J Van Hof-van Duin, D J Heersema, et al.
Journal of Clinical Pharmacy and Therapeutics|May 12, 2010
Body weight gain induced by atypical antipsychotics: an extension of the monozygotic twin and sib pair studyS Gebhardt, F M Theisen, M Haberhausen, et al.
Molecular Psychiatry|December 12, 2002
5-HT2A promoter polymorphism -1438G/A in children and adolescents with obsessive-compulsive disordersS Walitza, C Wewetzer, A Warnke, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|August 24, 1999
No evidence for an involvement of alleles of polymorphisms in the serotonin1Dbeta and 7 receptor genes in obesity, underweight or anorexia nervosaA Hinney, H Herrmann, T Löhr, et al.
Molecular Psychiatry|July 1, 1997
Low leptin levels predict amenorrhea in underweight and eating disordered femalesW Köpp, W F Blum, S von Prittwitz, et al.
European Child & Adolescent Psychiatry|October 13, 2005
12-month efficacy and safety of OROS MPH in children and adolescents with attention-deficit/hyperactivity disorder switched from MPHPeter Hoare, H Remschmidt, R Medori, et al.
Pageof 21